Could cause temporary or reversible harm; serious harm is unlikely.
Presence of Particulate Matter: Hair was found in products
| Brand name | XYLOCAINE |
| Generic name | LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE |
| Active ingredient(s) | LIDOCAINE HYDROCHLORIDE ANHYDROUS, EPINEPHRINE BITARTRATE |
| Distributed by / for | Fresenius Kabi USA, LLC |
| Full product label | Xylocaine (lidocaine HCl Injection, USP), 1%, 500 mg per 50 mL (10 mg per mL), 25 Multiple-Dose Vials, 50 mL, Rx only, Sterile, Fresenius Kabi, Lake Zurich, IL 60047 NDC Tray: 63323-485-57; NDC Vial: 63323-485-03 |
| Recalling firm | Fresenius Kabi USA, LLC |
| Distribution | Nationwide within in the USA |
| Quantity | 37,250 vials |
| Recall initiated | 2026-07-16 |
| Report date | 2026-07-29 |
| Recall completed | — |
| Recall number | D-0729-2026 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Lake Zurich IL United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗